nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

01.11.2003 | Concise Article

Pulmonary Aspergillosis in a Patient with Chronic Granulomatous Disease: Confirmation by Polymerase Chain Reaction and Serological Tests, and Successful Treatment with Voriconazole

verfasst von: H. Sambatakou, M. Guiver, D. Denning

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 11/2003

Einloggen, um Zugang zu erhalten

Abstract

A 25-year-old male with chronic granulomatous disease developed severe bilateral pulmonary aspergillosis confirmed by a positive result of polymerase chain reaction for Aspergillus species from sputum and positive serological tests for Aspergillus. He was successfully treated with voriconazole. The diagnostic difficulties and the new therapeutic options in the era of new antifungal agents are discussed.

Dinauer M, Orkin S, Brown R, Jesaitis A, Parkos C (1987) The glycoprotein encoded by the X-linked chronic granulomatous disease locus in a component of the neutrophil cytochrome b complex. Nature 327:717–720CrossRefPubMed

Jirapongsananuruk O, Niemela JE, Malech HL, Fleisher TA (2002) CYBB mutation analysis in X-linked chronic granulomatous disease. Clin Immunol 104:73–76CrossRefPubMed

Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C (1989) Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 114:555–560PubMed

Finn A, Hadzic N, Morgan G, Strobel S, Levinsky RJ (1990) Prognosis of chronic granulomatous disease. Arch Dis Child 65:942–945PubMed

Loeffler J, Schmidt K, Hebart H, Schumacher U, Einsele H (2002) Automated extraction of genomic DNA from medically important yeast species and filamentous fungi by using the MagNA Pure LC system. J Clin Microbiol 40:2240–2243CrossRefPubMed

Kami M, Fukui T, Ogawa S, Kazuyama Y, Machida U, Tanaka Y, Kanda Y, Kashima T, Yamazaki Y, Hamaki T, Mori S, Akiyama H, Mutou Y, Sakamaki H, Osumi K, Kimura S, Hirai H (2001) Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis 33:1504–1512PubMed

Liese J, Kloos S, Jendrossek V, Petropoulou T (2000) Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 137:687–693PubMed

Casson DH, Riordan FA, Ladusens EJ (1996) Aspergillus endocarditis in chronic granulomatous disease. Acta Paediatr 85:758–759PubMed

Gupta PK, Mahapatra AK, Gaind R, Bhandari S, Musa MM, Lad SD (2001). Aspergillus spinal epidural abscess. Pediatr Neurosurg 35:18–23CrossRefPubMed

10.

Margolis DM, Melnick DA, Alling DW, Gallin JI (1990) Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis 162:723–726PubMed

11.

Progrebniak H, Gallin J, Malech H, Baker A, Moskaluk C, Travis W, Pass H (1993) Surgical management of pulmonary infections in chronic granulomatous disease of childhood. Ann Thorac Surg 55:844–849PubMed

12.

Roilides E, Sigler L, Bibashi E, Katsifa H, Flaris N, Panteliadis C (1999) Disseminated infection due to Chrysosporium zonatum in a patient with chronic granulomatous disease and review of non-Aspergillus fungal infections in patients with this disease. J Clin Microbiol 37:18–25PubMed

13.

Jabado N, Casanova JL, Haddad E, Dulieu F, Fournet JC, Dupont B, Fischer A, Hennequin C, Blanche S (1998) Invasive pulmonary infection due to Scedosporium apiosperum in two children with chronic granulomatous disease. Clin Infect Dis 27:1437–1441PubMed

14.

Mouy R, Veber F, Blanche S, Donadieu J, Brauner R, Levron JC, Griscelli C, Fischer A (1994) Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease. J Pediatr 125:998–1003PubMed

15.

Casale TB, Macher AM, Fauci AS (1984) Concomitant pulmonary aspergillosis and nocardiosis in a patient with chronic granulomatous disease of childhood. South Med J 77:274–275PubMed

16.

Olive D, Burioti D, Brocard O, Griscelli C (1979) Pulmonary aspergillosis and chronic septic granulomatosis. Arch Fr Pediatr 36:298–302PubMed

17.

Abati A, Cajigas A, Holland SM, Solomon D (1996) Chronic granulomatous disease of childhood: respiratory cytology. Diagn Cytopathol 15:98–102CrossRefPubMed

18.

Dorman SE, Guide SV, Conville PS, DeCarlo ES, Malech HL, Gallin JI, Witebsky FG, Holland SM (2002) Nocardia infection in chronic granulomatous disease. Clin Infect Dis 35:390–394CrossRefPubMed

19.

Roback SA, Weintraub WH, Good RA et al. (1971) Chronic granulomatous disease of childhood: surgical considerations. J Pediatr Surg 6:601–611PubMed

20.

Bretagne S, Costa MJ, Bart-Delabesse E, Dhedin N, Rieux C, Cordonnier C (1998) Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis. Clin Infect Dis 26:1407–1412PubMed

21.

Verweij PE, Latge JP, Rijs AJMM, Melchers WJG, De Pauw BE, Hoogkamp-Korstanje JAA, Meis JFGM (1995) Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for haematological malignancies. J Clin Microbiol 33:3150–3153PubMed

22.

Ascioglou S, Rex JH, de Pauw B, Bennet JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34:7–14PubMed

23.

Tsuge I, Makimura K, Natsume J, Kubota T, Hasegawa S, Kawabe T, Nakashima S, Aso K, Negoro T, Watanabe K (1998) Successful polymerase chain reaction-based diagnosis of fungal meningitis in a patient with chronic granulomatous disease. Acta Paediatr Jpn 40:356–359PubMed

24.

Maertens J, Verhaegen J, Demuynck H, Brock P, Verhoef G, Vandenberghe P, Van Elderle J, Verbist L, Boogaerts M (1999) Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for haematological patients at risk for invasive aspergillosis. J Clin Microbiol 37:3223–3228PubMed

25.

Verweij PE, Weemaes CM, Curfs Jo HAJ, Bretagne S, Meis JFGM (2000) Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis. J Clin Microbiol 38:3900–3901PubMed

26.

Eppinger TM, Greenberger PA, White DA, Brown AE, Cunningham-Rundles C (1999) Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome. J Allergy Clin Immunol 104:1265–1272PubMed

27.

Saulsbury FT (2001) Successful treatment of Aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease. Clin Infect Dis 32:137–139CrossRef

28.

Spencer DA, John P, Ferryman SR, Weller PH, Darbyshire P (1994) Successful treatment of invasive pulmonary aspergillosis in chronic granulomatous disease with orally administered itraconazole suspension. Am J Respir Crit Care Med 149:239–241PubMed

29.

Kloss S, Schuter A, Schroten H, Lamprecht J, Wahn V (1991) Control of proven pulmonary and suspected CNS Aspergillus infection with itraconazole in a patient with chronic granulomatous disease. Eur J Pediatr 150:483–485PubMed

30.

Bernhisel-Broadbent J, Camargo EE, Jaffe HS, Lederman HM (1991) Recombinant human interferon-gamma as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease. J Infect Dis 163:908–911PubMed

31.

Touza Rey F, Martinez Vasquez C, Alonso Alonso J, Mendez Pineiro MJ, Rubianes Gonzalez M, Crespo Casal M (2000) The clinical response to interferon-gamma in a patient with chronic granulomatous disease and brain abscesses due to Aspergillus fumigatus. Ann Intern Med 17:86–87

32.

Denning WD, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E, Haas A, Ruhnke M, Lode H (2002) Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 34:563–571CrossRefPubMed

33.

Herbrecht R, Denning WD, Patterson FT, Bennett EJ, Greene ER, Oestmann WJ, Kern VW, Marr K, Ribaud P, Lortholary O et al. (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408–415PubMed

34.

Walsh TJ, Lutsar I, Driscoll T, Dupont B, Roden M, Ghahramani P, Hodges M, Groll AH, Perfect JR (2002) Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 21:240–248PubMed

35.

Hek LG van’t, Verweij PE, Weemaes CM, Dalen R van, Yntema JB, Meis JF (1998) Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease. Am J Respir Crit Care Med 157:1694–1696PubMed

36.

Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M, Reiffers J, Cardinaud J (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344:481–487PubMed

Titel: Pulmonary Aspergillosis in a Patient with Chronic Granulomatous Disease: Confirmation by Polymerase Chain Reaction and Serological Tests, and Successful Treatment with Voriconazole
verfasst von: H. Sambatakou
M. Guiver
D. Denning
Publikationsdatum: 01.11.2003
Verlag: Springer-Verlag
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 11/2003
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-003-1007-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2003

Meropenem Prevents Levofloxacin-Induced Resistance in Penicillin-Resistant Pneumococci and Acts Synergistically with Levofloxacin in Experimental Meningitis

Rapid Identification of Yeasts Commonly Found in Positive Blood Cultures by Amplification of the Internal Transcribed Spacer Regions 1 and 2

Impaired Recovery of CD4+ Cell Counts Following Highly Active Antiretroviral Therapy in Drug-Naïve Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus

Nosocomial Cluster of Candida guillermondii Fungemia in Surgical Patients

Declining Incidence of AIDS and Increasing Prevalence of AIDS Presenters Among AIDS Patients in Italy